IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kernacki, K. A.
Right arrow Articles by Berk, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kernacki, K. A.
Right arrow Articles by Berk, R. S.

Investigative Ophthalmology & Visual Science, Vol 36, 1371-1378, Copyright © 1995 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection [published erratum appears in Invest Ophthalmol Vis Sci 1995 Sep;36(10):1947]

KA Kernacki, JA Hobden, LD Hazlett, R Fridman and RS Berk
Department of Immunology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

PURPOSE. To establish if active pseudomonal proteases are present in vivo during corneal infection with Pseudomonas aeruginosa and to determine if the mouse strains used in these and previous studies have the ability to mount a nonocular antibody response to the purified proteases because antibodies to the bacterial proteases were not detected previously during in vivo ocular infection. METHODS. At certain times after corneal infection with P. aeruginosa, corneas were harvested and supernatants from the corneal homogenates were analyzed for proteolytic activity by zymography and immunoreactivity by immunoblotting. The efficiency of the extraction procedures used in these studies was determined by incubating uninfected corneal homogenates with the purified proteases. The resultant supernatants were analyzed for alkaline protease and elastase activity. Additionally, mice were immunized intraperitoneally with the purified proteases with and without adjuvant to determine if the animals could mount a nonocular antibody response. RESULTS. Corneas infected with P. aeruginosa demonstrated the presence of alkaline protease, but not elastase, by the two methods examined. The kinetics of the in vivo alkaline protease response closely parallels previously reported bacterial clearance studies in that peak alkaline protease activity was detected in corneal tissue when peak bacterial numbers also were observed in the eye, and it was absent when the eyes were sterile or nearly sterile. In addition, C57BL/6J mice were capable of mounting a nonocular antibody response to microgram quantities of both proteases only in the presence of adjuvant. CONCLUSIONS. In the model described, enzymatically active alkaline protease, but not elastase, was demonstrated in corneal tissues during in vivo infection. Concentrations of these proteases were much lower than those required to stimulate an antibody response.


This article has been cited by other articles:


Home page
IOVSHome page
J. A. Lomholt and M. Kilian
Degradation of Uniquely Glycosylated Secretory Immunoglobulin A in Tears from Patients with Pseudomonas aeruginosa Keratitis
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4939 - 4944.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. J. O'Callaghan, C. C. McCormick, A. R. Caballero, M. E. Marquart, H. P. Gatlin, and J. D. Fratkin
Age-Related Differences in Rabbits during Experimental Staphylococcus aureus Keratitis
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5125 - 5131.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Thakur, R. P. Barrett, J. A. Hobden, and L. D. Hazlett
Caspase-1 Inhibitor Reduces Severity of Pseudomonas aeruginosa Keratitis in Mice
Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3177 - 3184.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Caballero, B. Thibodeaux, M. Marquart, M. Traidej, and R. O'Callaghan
Pseudomonas Keratitis: Protease IV Gene Conservation, Distribution, and Production Relative to Virulence and Other Pseudomonas Proteases
Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 522 - 530.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. P. Aristoteli and M. D. P. Willcox
Mucin Degradation Mechanisms by Distinct Pseudomonas aeruginosa Isolates In Vitro
Infect. Immun., October 1, 2003; 71(10): 5565 - 5575.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Thakur, M. Xue, F. Stapleton, A. R. Lloyd, D. Wakefield, and M. D. P. Willcox
Balance of Pro- and Anti-Inflammatory Cytokines Correlates with Outcome of Acute Experimental Pseudomonas aeruginosa Keratitis
Infect. Immun., April 1, 2002; 70(4): 2187 - 2197.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. A. Kernacki, R. P Barrett, S. McClellan, and L. D. Hazlett
MIP-1{alpha} regulates CD4+ T cell chemotaxis and indirectly enhances PMN persistence in Pseudomonas aeruginosa corneal infection
J. Leukoc. Biol., December 1, 2001; 70(6): 911 - 919.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. S. Berk, M. Katar, Z. Dong, and D. E. Day
Plasminogen Activators and Inhibitors in the Corneas of Mice Infected with Pseudomonas aeruginosa
Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1561 - 1567.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
A. Thakur, J. Kyd, M. Xue, M. D. P. Willcox, and A. Cripps
Effector Mechanisms of Protection against Pseudomonas aeruginosa Keratitis in Immunized Rats
Infect. Immun., May 1, 2001; 69(5): 3295 - 3304.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Z. Dong, M. Ghabrial, M. Katar, R. Fridman, and R. S. Berk
Membrane-Type Matrix Metalloproteinases in Mice Intracorneally Infected with Pseudomonas aeruginosa
Invest. Ophthalmol. Vis. Sci., December 1, 2000; 41(13): 4189 - 4194.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
X. L. Rudner, K. A. Kernacki, R. P. Barrett, and L. D. Hazlett
Prolonged Elevation of IL-1 in Pseudomonas aeruginosa Ocular Infection Regulates Macrophage-Inflammatory Protein-2 Production, Polymorphonuclear Neutrophil Persistence, and Corneal Perforation
J. Immunol., June 15, 2000; 164(12): 6576 - 6582.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Kernacki, R. P. Barrett, J. A. Hobden, and L. D. Hazlett
Macrophage Inflammatory Protein-2 Is a Mediator of Polymorphonuclear Neutrophil Influx in Ocular Bacterial Infection
J. Immunol., January 15, 2000; 164(2): 1037 - 1045.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. A. Kernacki, R. Barrett, and L. D. Hazlett
Evidence for TIMP-1 Protection Against P. aeruginosa-Induced Corneal Ulceration and Perforation
Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3168 - 3176.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. S. Engel, J. M. Hill, A. R. Caballero, L. C. Green, and R. J. O'Callaghan
Protease IV, a Unique Extracellular Protease and Virulence Factor from Pseudomonas aeruginosa
J. Biol. Chem., July 3, 1998; 273(27): 16792 - 16797.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. E. Feltzer, R. D. Gray, W. L. Dean, and W. M. Pierce Jr.
Alkaline Proteinase Inhibitor of Pseudomonas aeruginosa. INTERACTION OF NATIVE AND N-TERMINALLY TRUNCATED INHIBITOR PROTEINS WITH PSEUDOMONAS METALLOPROTEINASES
J. Biol. Chem., July 7, 2000; 275(28): 21002 - 21009.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the Association for Research in Vision and Ophthalmology